Please login to the form below

hypoglycaemia

This page shows the latest hypoglycaemia news and features for those working in and with pharma, biotech and healthcare.

Sanofi reveals positive phase 3 results for long-acting insulin Toujeo

In addition, the percentage of participants who experienced severe hypoglycaemia and who experienced high blood sugar (hyperglycaemic) events were similar. ... The number of patients experiencing severe hypoglycaemia and who experienced hyperglycaemia

Latest news

Vertex eyes type 1 diabetes cure with biotech acquisition

The biotech has advanced the ability to produce large quantities of functional human pancreatic beta cells that restore insulin production and ameliorate hypoglycaemia in animal tests.
Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease

increased risk of side effects like hypoglycaemia or lactic acidosis.
Novo spends $800m to buy biotech and 'glucose responsive insulin' tech

Combining this technology with Novo Nordisk’s insulin to create GRIs would ultimately help further its goal of eliminating the risk of hypoglycaemia, the main risk associated with insulin therapy. ... have the potential to lead to the development of
FDA starts review of Sanofi’s oral type 1 diabetes drug

The results suggest adding the drug to insulin therapy can improve glucose control as measured by haemoglobin A1c levels, with a reduced risk of potentially dangerous low blood sugar levels (hypoglycaemia).
Novo says real-world data backs its insulin switching

Rates of overall hypoglycaemia were also significantly lower after switching to Tresiba, falling 85% in type 1 and 92% in type 2 patients at six months. ... compare the two drugs on not only glucose control and hypoglycaemia but also cardiovascular

More from news
Approximately 2 fully matching, plus 86 partially matching documents found.

Latest Intelligence

Case study: The KiDS project in India and Brazil

For example, poorly controlled levels of blood sugar can result in frightening and potentially damaging hypoglycaemia and hyperglycaemia.
Interview: Peter Meeus, Novo Nordisk

end of last year and has demonstrated it is as effective in reducing blood glucose levels as is its rival Lantus from Sanofi, yet carries less risk of hypoglycaemia. ... In addition, Meeus highlighted a need to raise awareness among the healthcare
Interview: Pierre Chancel, Sanofi Diabetes

2 diabetes further reduce HbA1c, with the benefit of weight loss and limited risk of hypoglycaemia.”.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

How technology is shaping patient education

The simulation showed the high impact of mild hypoglycaemia (low blood sugar) on a patient; it made the viewer ‘feel’ the symptoms of hypoglycaemia in various scenarios through a typical day

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...